| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/19/2008 | EP1200137B1 Agent for occluding blood vessels |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | CN101146792A Crystalline forms of a known pyrrolidine factor Xa inhibitor |
| 03/19/2008 | CN101146781A Spirocyclic thrombin receptor antagonists |
| 03/19/2008 | CN101146537A Therapeutic agent for thrombosis |
| 03/19/2008 | CN101143221A Central airway administration for systemic delivery of therapeutics |
| 03/19/2008 | CN101143211A Method for producing heatproof human fiber collagen |
| 03/19/2008 | CN101143011A Method for improving iron bioavailability in food |
| 03/19/2008 | CN101143004A Moxa leaf rice paste and its making method |
| 03/19/2008 | CN101142984A Cake capable of enriching blood function and its making technique |
| 03/19/2008 | CN100375630C Compound drop pills with flavescent sophora root and its preparation method |
| 03/19/2008 | CN100375628C A medicine for treating vaginal bleeding caused by drug induced abortion and method for preparing the same |
| 03/19/2008 | CN100375623C Compound medicine for treating meat chicken ascites |
| 03/18/2008 | US7345070 Side effects reduction; Diabetes mellitus, Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; 3-{4-[2-(2-phenyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid |
| 03/18/2008 | US7345047 7-[7-[2-cycloalkyl]amino]-5-(propylthio)--3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]spiro[2.4]heptane-4,5,6-triol from spiro[2.4]hept-5-ene-4,7diol Diacetate and 4,6-dichloro-5-nitro-3-propylthiopyrimidine intermediates; for P2T (P2Y(ADP) or P2T(AC)) receptor antagonists; antithrombotics; unstable angina |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2102494C A pharmaceutical composition containing a defined lipid system |
| 03/13/2008 | WO2008030836A2 Bcl inhibitors treating platelet excess |
| 03/13/2008 | WO2008029912A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008028410A1 Use of low molecular weight fucoidan in the preparation of medicament for the treatment of cardiovascular and cerebrovascular diseases |
| 03/13/2008 | WO2008028314A1 Catechol derivatives, composition and application thereof |
| 03/13/2008 | WO2007132445A8 Use of non-catalytic form of heparanase and peptides thereof for reversing the anti-coagulant effects of heparinoids |
| 03/13/2008 | WO2007126365A3 Further medical uses of antisecretory protein |
| 03/13/2008 | US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3 |
| 03/13/2008 | US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064628 Injectable synthetic blood clotting compositions containing peptide bound to insoluble carrier; selectively binding activated platelets to fibrinogen; treating wounds in patients with thrombocytopenia |
| 03/13/2008 | US20080063671 Hemostatic bone graft |
| 03/13/2008 | US20080063631 prophylaxis of vascular system disorders in mammals by administering apoptotic cells and/or bodies derived from leukocytes or lymphocytes |
| 03/13/2008 | US20080063629 culturing progenitor or stem cells with stromal cells in cytokines; genetic engineering |
| 03/13/2008 | US20080063624 administering compounds which bind to the chemokine receptors, such as 1,1'-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane, optionally with colony stimulating factors, to effect regeneration of dead myocardium |
| 03/13/2008 | CA2662320A1 Bcl inhibitors treating platelet excess |
| 03/12/2008 | EP1897556A1 Prevention and treatment of hypergastrinemia |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896483A2 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 03/12/2008 | EP1896466A1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/12/2008 | EP1896417A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1434590B1 Method for inhibiting the formation of seromas using factor xiii |
| 03/12/2008 | EP1389998A4 Method and apparatus for computer modeling diabetes |
| 03/12/2008 | EP1265648B1 NOVEL collagen-BASED MATERIAL WITH IMPROVED PROPERTIES FOR USE IN HUMAN AND VETERINARY MEDICINE AND THE METHOD OF MANUFACTURING SUCH |
| 03/12/2008 | EP1225184B1 Human antithrombin variants |
| 03/12/2008 | EP0833659B1 Therapeutic fragments of von willebrand factor |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142218A Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 03/12/2008 | CN101142212A 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 03/12/2008 | CN101139578A Double-functional staphylokinase mutant having platelet aggregation resistance and fibrinolytic activity, application and preparation method thereof |
| 03/12/2008 | CN101139346A Benzimidazole-derivatives as factor Xa inhibitors |
| 03/12/2008 | CN101138632A Compound stypticum |
| 03/12/2008 | CN101138630A Fibrin glue composition for repairing nerve damage and methods thereof |
| 03/12/2008 | CN101138596A Prescription of traditional Chinese medicine hyssop health lozenge |
| 03/12/2008 | CN101138592A Preparation method for treating internal hemorrhoid and Chinese medicine suppository thereof |
| 03/12/2008 | CN101138579A Astragalus root fermentation liquor and uses thereof |
| 03/12/2008 | CN101138574A Wine-fried angelica decocting pieces, preparation method thereof and application thereof |
| 03/12/2008 | CN101138565A Platelet aggregation-against pharmaceutical composition and method of preparing the same |
| 03/12/2008 | CN101138545A Clathrate compound containing ginsenoside Rg2 and method of preparing the same |
| 03/12/2008 | CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 03/12/2008 | CN100374121C Tillering onion extract and its application |
| 03/12/2008 | CN100374119C Pseudo-ginseng saponin oral disintegration tablet and preparing method |
| 03/11/2008 | US7342039 Substituted indole oximes |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7342013 Benzamides and related inhibitors of factor Xa |
| 03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
| 03/11/2008 | US7341716 Solidifying mass in an ionic fluid- containing bodily cavity using polymer comprising 2-cyanoacrylate monomer |
| 03/07/2008 | CA2599849A1 Synthetic platelets |
| 03/06/2008 | WO2008026720A1 Antibody capable of enhancing activation of blood coagulation factor viii |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008025822A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025069A1 Methods of modulating cellular activity and compositions therefor |
| 03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 03/06/2008 | US20080058353 Using 3-(7-(2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3triazolo(4,5)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane( 1 ,2-diol |
| 03/06/2008 | US20080058303 Antiinflammatory agents |
| 03/06/2008 | US20080058269 Insulin Releasing Peptides |
| 03/06/2008 | US20080058266 Pharmaceutical Compositions Comprising Factor VII Polypeptides and Factor XI Polypeptides |
| 03/06/2008 | US20080058256 Metalloproteinase polypeptide; in vivo lysis of blood clots; genetic engineering; gene expression |
| 03/06/2008 | US20080058255 Human coagulation polypeptides, polynucleotides |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057059 Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein S Inhibitors |
| 03/06/2008 | US20080057057 Anti-Lipid Rafts Antibodies |
| 03/06/2008 | US20080057030 comprising administering an effective amount of Interferon-gamma (IFN-gamma) and corticosteroids; treatment of respiratory system disorders |
| 03/06/2008 | DE102006039589A1 Aminoacyl-Prodrugs II Aminoacyl prodrugs II |
| 03/06/2008 | CA2661850A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/05/2008 | EP1894911A1 Vitamin d-like compound |
| 03/05/2008 | EP1894576A1 Novel triglyceride reducing agent |
| 03/05/2008 | EP1894573A2 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 03/05/2008 | EP1894567A1 Concomitant pharmaceutical agents and use thereof |
| 03/05/2008 | EP1893601A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives |
| 03/05/2008 | EP1893600A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 03/05/2008 | EP1893230A2 Use of modified factor vii for treating bleeding |
| 03/05/2008 | EP1893186A2 Improved treatment for anemia using a hif-alpha stabilising agent |
| 03/05/2008 | EP1383756B1 Coumarin derivatives to be used as anticoagulants |
| 03/05/2008 | CN101137655A Androgen receptor modulator compounds and methods |